Hims Dives After Its Lilly-Rivaling Obesity Plan Faces An Unexpected Hitch
Hims stock reversed lower Wednesday as analysts laid out low expectations for Him & Hers' branded tirzepatide. The post Hims Dives After Its Lilly-Rivaling Obesity Plan Faces An Unexpected Hitch appeared first on Investor's Business Daily.
Hims stock reversed lower Wednesday as analysts laid out low expectations for Him & Hers' branded tirzepatide.
The post Hims Dives After Its Lilly-Rivaling Obesity Plan Faces An Unexpected Hitch appeared first on Investor's Business Daily.
iShook Opinion
"iShook Opinion" by Beni E Rachmanov, CEO & Founder of iShook. Explore captivating perspectives on entertainment, lifestyle, and sports at ishookdaily.com. Your go-to for engaging insights.
